Spectrum Pharmaceuticals Stock Price - SPPI

-0.025 (-0.84%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Spectrum Pharmaceuticals Inc SPPI NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.025 -0.84% 2.965 2.90 3.04 3.04 2.99 11:54:03
Bid Price Ask Price Spread Spread % News
2.96 2.97 0.01 0.34% - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,022 778,135 $ 2.97 $ 2,312,692 1,210,279 1.7422 - 10.57
Last Trade Time Type Quantity Stock Price Currency
11:54:30 100 $ 2.965 USD

Spectrum Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 345.33M 116.47M 112.97M $ - $ - -1.02 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 7.00 3.00%

more financials information »

Spectrum Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SPPI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.313.432.903.131,148,835-0.345-10.42%
1 Month2.963.442.603.041,258,9180.0050.17%
3 Months2.943.441.74222.641,342,2710.0250.85%
6 Months8.8510.571.74223.602,044,248-5.89-66.5%
1 Year7.9610.571.74224.811,383,815-5.00-62.75%
3 Years5.7225.291.742211.911,322,686-2.76-48.16%
5 Years6.2625.291.742210.201,111,650-3.30-52.64%

Spectrum Pharmaceuticals Description

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors. The SPI-2012 is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN addresses immediate intravesical instillation and post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer.

Your Recent History
Spectrum P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.